133 related articles for article (PubMed ID: 10598194)
1. Foregut carcinoids: a clinical and biochemical analysis.
Kirshbom PM; Kherani AR; Onaitis MW; Hata A; Kehoe TE; Feldman C; Feldman JM; Tyler DS
Surgery; 1999 Dec; 126(6):1105-10. PubMed ID: 10598194
[TBL] [Abstract][Full Text] [Related]
2. Gastrointestinal carcinoids: characterization by site of origin and hormone production.
Onaitis MW; Kirshbom PM; Hayward TZ; Quayle FJ; Feldman JM; Seigler HF; Tyler DS
Ann Surg; 2000 Oct; 232(4):549-56. PubMed ID: 10998653
[TBL] [Abstract][Full Text] [Related]
3. Gastrointestinal carcinoid tumors: factors that predict outcome.
Van Gompel JJ; Sippel RS; Warner TF; Chen H
World J Surg; 2004 Apr; 28(4):387-92. PubMed ID: 14994141
[TBL] [Abstract][Full Text] [Related]
4. Carcinoids of unknown origin: comparative analysis with foregut, midgut, and hindgut carcinoids.
Kirshbom PM; Kherani AR; Onaitis MW; Feldman JM; Tyler DS
Surgery; 1998 Dec; 124(6):1063-70. PubMed ID: 9854584
[TBL] [Abstract][Full Text] [Related]
5. Neuroendocrine secretory protein-55 (NESP-55) expression discriminates pancreatic endocrine tumors and pheochromocytomas from gastrointestinal and pulmonary carcinoids.
Srivastava A; Padilla O; Fischer-Colbrie R; Tischler AS; Dayal Y
Am J Surg Pathol; 2004 Oct; 28(10):1371-8. PubMed ID: 15371954
[TBL] [Abstract][Full Text] [Related]
6. Current diagnosis and treatment of gastrointestinal carcinoids in a series of 101 patients: the significance of serum chromogranin-A, somatostatin receptor scintigraphy and somatostatin analogues.
Nikou GC; Lygidakis NJ; Toubanakis C; Pavlatos S; Tseleni-Balafouta S; Giannatou E; Mallas E; Safioleas M
Hepatogastroenterology; 2005; 52(63):731-41. PubMed ID: 15966194
[TBL] [Abstract][Full Text] [Related]
7. Prospective study of the ability of histamine, serotonin or serum chromogranin A levels to identify gastric carcinoids in patients with gastrinomas.
Bashir S; Gibril F; Ojeaburu JV; Asgharian B; Entsuah LK; Ferraro G; Crafa P; Bordi C; Jensen RT
Aliment Pharmacol Ther; 2002 Jul; 16(7):1367-82. PubMed ID: 12144588
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical staining for CDX-2, PDX-1, NESP-55, and TTF-1 can help distinguish gastrointestinal carcinoid tumors from pancreatic endocrine and pulmonary carcinoid tumors.
Srivastava A; Hornick JL
Am J Surg Pathol; 2009 Apr; 33(4):626-32. PubMed ID: 19065104
[TBL] [Abstract][Full Text] [Related]
9. Clinical presentation and prognosis of gastrointestinal carcinoid tumours.
Sjöblom SM
Scand J Gastroenterol; 1988 Sep; 23(7):779-87. PubMed ID: 3227292
[TBL] [Abstract][Full Text] [Related]
10. Carcinoid tumors in the gastrointestinal tract--an analysis of 156 cases.
Mårtensson H; Nobin A; Sundler F
Acta Chir Scand; 1983; 149(6):607-16. PubMed ID: 6650073
[TBL] [Abstract][Full Text] [Related]
11. Carcinoids of the pancreas: an analysis of 156 cases.
Soga J
Cancer; 2005 Sep; 104(6):1180-7. PubMed ID: 16104045
[TBL] [Abstract][Full Text] [Related]
12. Immunocytochemical localization of prohormone convertase 1/3 and 2 in gastrointestinal carcinoids.
Tomita T
Endocr Pathol; 2001; 12(2):137-45. PubMed ID: 11579679
[TBL] [Abstract][Full Text] [Related]
13. Carcinoid tumors of the gastrointestinal tract.
Morgan JG; Marks C; Hearn D
Ann Surg; 1974 Nov; 180(5):720-7. PubMed ID: 4421375
[TBL] [Abstract][Full Text] [Related]
14. 7201 carcinoids: increasing incidence overall and disproportionate mortality in the elderly.
Perez EA; Koniaris LG; Snell SE; Gutierrez JC; Sumner WE; Lee DJ; Hodgson NC; Livingstone AS; Franceschi D
World J Surg; 2007 May; 31(5):1022-30. PubMed ID: 17429568
[TBL] [Abstract][Full Text] [Related]
15. The impact of incidental identification on the stage at presentation of lower gastrointestinal carcinoids.
Buitrago D; Trencheva K; Zarnegar R; Finnerty B; Aldailami H; Lee SW; Sonoda T; Milsom JW; Fahey TJ
J Am Coll Surg; 2011 Nov; 213(5):652-6. PubMed ID: 21880512
[TBL] [Abstract][Full Text] [Related]
16. Cytokeratin 7 and 20 and thyroid transcription factor 1 can help distinguish pulmonary from gastrointestinal carcinoid and pancreatic endocrine tumors.
Cai YC; Banner B; Glickman J; Odze RD
Hum Pathol; 2001 Oct; 32(10):1087-93. PubMed ID: 11679943
[TBL] [Abstract][Full Text] [Related]
17. Carcinoid tumours.
Tiensuu Janson EM; Oberg KE
Baillieres Clin Gastroenterol; 1996 Dec; 10(4):589-601. PubMed ID: 9113314
[TBL] [Abstract][Full Text] [Related]
18. Neuroendocrine tumors of the gastrointestinal tract.
Chejfec G; Falkmer S; Askensten U; Grimelius L; Gould VE
Pathol Res Pract; 1988 Apr; 183(2):143-54. PubMed ID: 3290866
[TBL] [Abstract][Full Text] [Related]
19. The visualization of gastroenteropancreatic endocrine tumors.
Lamberts SW; Chayvialle JA; Krenning EP
Digestion; 1993; 54 Suppl 1():92-7. PubMed ID: 8395433
[TBL] [Abstract][Full Text] [Related]
20. Comparative studies on the expression of somatostatin receptor subtypes, outcome of octreotide scintigraphy and response to octreotide treatment in patients with carcinoid tumours.
Nilsson O; Kölby L; Wängberg B; Wigander A; Billig H; William-Olsson L; Fjälling M; Forssell-Aronsson E; Ahlman H
Br J Cancer; 1998 Feb; 77(4):632-7. PubMed ID: 9484822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
